코로나19 백신 개발사 큐어백 “임상시험서 면역반응” German biotech company, CureVac, recorded an immune reaction from a potential vaccine in a clinical trial on Monday. According to local media outlets, its CEO Franz-Werner Haas was encouraged by the interim results from…
코로나19 백신 “모든 투약자 면역 반응 생성”…글로벌 혈장치료 임상도 40배 늘어 Some promising signs of vaccines and treatments for COVID-19 are emerging. Scientists at Oxford University in the U.K. say their experimental vaccine has led to an immune response in…
“러시아 자체 개발 코로나19 백신 첫 임상시험 성공” Has Russia become the first country to develop a COVID-19 vaccine? Moscow says it has successfully completed trials on humans,… yet no further details on when the vaccine will be released were…
“항체 생성률 낮아…치료제 나올 때까지 방역대책 철저해야” New research suggests only a small percentage of recovered COVID-19 patients generate an antibody to the virus that would prevent them from contracting it over and over again. The researchers say that means…
